- HOME
- Rinsho Shinkeigaku (Clinical Neurology)
- Vol.54 No.12
Vol.54 No.12 contents
Presidential Address
My way to "Keep Pioneering": Integrated neuroscience and immunology research produces a paradigm shift for intractable neurological disease
Jun-ichi Kira, M.D., Ph.D.1)
CLINICA NEUROL, 54: 939|946, 2014
Educational Lecture Basic 09
Myasthenia gravis: Past, present and future
Hiroyuki Murai, M.D., Ph.D.1)
CLINICA NEUROL, 54: 947|949, 2014
Lecture Series 06-1
Diagnosis and care of Charcot-Marie-Tooth disease
Masanori Nakagawa, M.D.1)
CLINICA NEUROL, 54: 950|952, 2014
Lecture Series 06-2
Clinical diversity, diagnosis and treatment of hereditary amyloid neuropathy
Yoshiki Sekijima, M.D., Ph.D.1)2)
CLINICA NEUROL, 54: 953|956, 2014
Lecture Series 06-3
Clinical practice of hereditary motor neuropathy (HMN) and hereditary sensory and autonomic neuropathy (HSAN)
Hiroshi Takashima, M.D., Ph.D.1)2)
CLINICA NEUROL, 54: 957|959, 2014
Fields around Neurology 05
A magnetoencephalographic study on the disruption of the neural network
Shozo Tobimatsu, M.D., Ph.D.,1)
CLINICA NEUROL, 54: 960|962, 2014
Progress of the Year 2014
Clinical picture and diagnostic criteria
Hirohisa Watanabe, M.D.1), Mari Yoshida, M.D.2) and Gen Sobue, M.D.3)
CLINICA NEUROL, 54: 963|965, 2014
Progress of the Year 2014
Multiple system atrophy and autophagy
Koichi Wakabayashi, M.D., Ph.D.1) and Kunikazu Tanji, Ph.D.1)
CLINICA NEUROL, 54: 966|968, 2014
Progress of the Year 2014
Susceptibility gene in multiple system atrophy (MSA)
Shoji Tsuji, M.D., Ph.D.1)
CLINICA NEUROL, 54: 969|971, 2014
Progress of the Year 2014
Sema4A as a biomarker predicting responsiveness to IFN β treatment
Yuji Nakatsuji, M.D.1)
CLINICA NEUROL, 54: 972|974, 2014
Progress of the Year 2014
A novel therapeutic target in neuromyelitis optica and multiple sclerosis: high mobility group box 1 (HMGB1)
Masahiro Mori, M.D., Ph.D.1)
CLINICA NEUROL, 54: 975|977, 2014
Progress of the Year 2014
Neurofascin: A novel target for combined central and peripheral demyelination
Nobutoshi Kawamura, M.D.1)
CLINICA NEUROL, 54: 978|980, 2014
Progress of the Year 2014
The role of microglia in inflammatory demyelination lesion in the central nervous system
Ryo Yamasaki, M.D., Ph.D.1)
CLINICA NEUROL, 54: 981|983, 2014
Symposium 03
Neuromuscular disease and sleep disturbance
Mitsuru Kawai, M.D.1)
CLINICA NEUROL, 54: 984|986, 2014
Symposium 03
Sleep disturbance in Parkinson's disease
Takashi Nomura, M.D., Ph.D.1), Yuichi Inoue, M.D., Ph.D.2) and Kenji Nakashima, M.D., Ph.D.1)
CLINICA NEUROL, 54: 987|990, 2014
Symposium 03
Headache and sleep disorders
Masayuki Miyamoto, M.D., Ph.D.1),Keisuke Suzuki, M.D., Ph.D.1), Tomoyuki Miyamoto, M.D., Ph.D.2) and Koichi Hirata, M.D., Ph.D.1)
CLINICA NEUROL, 54: 991|993, 2014
Symposium 03
Sleep problems in dementia
Yasunori Oka, M.D., M.Sc., Ph.D.1)
CLINICA NEUROL, 54: 994|996, 2014
Symposium 04
Progression from episodic migraine to chronic migraine
Kiyomi Yamane, M.D.1)
CLINICA NEUROL, 54: 997|999, 2014
Symposium 04
Migraine and stroke
Yasuhisa Kitagawa, M.D., Ph.D.1)
CLINICA NEUROL, 54: 1000|1002, 2014
Symposium 04
Migraine and epilepsy
Sadatoshi Tsuji, M.D.1)
CLINICA NEUROL, 54: 1003|1005, 2014
Symposium 04
Cortical spreading depression and pain: A missing link in the pathophysiology of migraine?
Hisanori Kowa, M.D., Ph.D.1), Hiroshi Takigawa, M.D., Ph.D.1) and Kenji Nakashima, M.D., Ph.D.1)
CLINICA NEUROL, 54: 1006|1008, 2014
Symposium 05
Hereditary spastic paraplegia: up to date
Yoshihisa Takiyama, M.D., Ph.D.1)
CLINICA NEUROL, 54: 1009|1011, 2014
Symposium 05
Clinical aspects of hereditary spastic paraplegias
Haruo Shimazaki, M.D., Ph.D.1)
CLINICA NEUROL, 54: 1012|1015, 2014
Symposium 05
Molecular genetics and gene analysis of hereditary spastic paraplegia
Hiroyuki Ishiura, M.D., Ph.D.1)
CLINICA NEUROL, 54: 1016|1017, 2014
Symposium 05
Intrathecal baclofen therapy for hereditary spastic paraplegia
Takaomi Taira, M.D., Ph.D.1) and Nobuhiko Takeda, M.D.1)
CLINICA NEUROL, 54: 1018|1020, 2014
Symposium 06
Revised Japanese guidelines for the clinical management of bacterial meningitis
Harumi Ishikawa, M.D., Ph.D.1) and Satoshi Kamei, M.D., Ph.D.1)
CLINICA NEUROL, 54: 1021|1023, 2014
Symposium 06
Diagnostic and therapeutic strategy for acyclovir-resistant herpes encephalitis
Masayuki Saijo, M.D., Ph.D.1)
CLINICA NEUROL, 54: 1024|1027, 2014
Symposium 06
A new approach for JC virus detection and its application for PML diagnosis
Kazuo Nakamichi, Ph.D.1), Chang-Kweng Lim, D.V.M., Ph.D.1) and Masayuki Saijo, M.D., Ph.D.1)
CLINICA NEUROL, 54: 1028|1030, 2014
Symposium 06
Identification of NMDA receptor in normal bovine ovary and ovum
Naoko Tachibana, M.D., Ph.D.1) and Shu-ichi Ikeda, M.D., Ph.D.2)
CLINICA NEUROL, 54: 1031|1033, 2014
Symposium 08
The evaluation of autonomic nervous function by assessing baroreceptor reflex
Toshimasa Yamamoto, M.D., Ph.D.1)
CLINICA NEUROL, 54: 1034|1037, 2014
Symposium 08
Evaluation of sudomotor function
Masato Asahina, M.D., Ph.D.1)
CLINICA NEUROL, 54: 1038|1040, 2014
Symposium 08
Sleep and autonomic function: Sleep related breathing disorders in Parkinson's disease and related disorders
Keisuke Suzuki, M.D., Ph.D.1), Masayuki Miyamoto, M.D., Ph.D.1), Tomoyuki Miyamoto, M.D., Ph.D.2) and Koichi Hirata, M.D., Ph.D.1)
CLINICA NEUROL, 54: 1041|1043, 2014
Symposium 08
Diagnosis of small-fiber neuropathy using various autonomic function tests.
Konen Obayashi, M.D., Ph.D.1) and Yukio Ando, M.D., Ph.D.2)
CLINICA NEUROL, 54: 1044|1046, 2014
Symposium 09
Clinicopathological features of neuropathy associated with IgG4-related disease
Ken Ohyama, M.D.1), Haruki Koike, M.D., Ph.D.1), Mie Takahashi, M.D.1), Yuichi Kawagashira, M.D., Ph.D.1), Masahiro Iijima, M.D., Ph.D.1) and Gen Sobue, M.D., Ph.D.1)
CLINICA NEUROL, 54: 1047|1049, 2014
Symposium 09
Vasculitic neuropathy: novel classification, diagnosis and treatment
Takashi Kanda, M.D.1)
CLINICA NEUROL, 54: 1050|1052, 2014
Symposium 09
Clinical features and MRI characteristics in neuralgic amyotrophy
Kazuhiro Fukushima, M.D., Ph.D.1)
CLINICA NEUROL, 54: 1053|1055, 2014
Symposium 09
Fisher syndrome and Bickerstaff brainstem encephalitis
Satoshi Kuwabara, M.D.1)
CLINICA NEUROL, 54: 1056|1057, 2014
Symposium 12
Cognitive impairment in multiple sclerosis
Masaaki Niino, M.D., Ph.D.1)
CLINICA NEUROL, 54: 1058|1059, 2014
Symposium 12
Gray matter lesions and cognitive impairment in multiple sclerosis
Izumi Kawachi, M.D., Ph.D.1), Etsuji Saji, M.D., Ph.D.1) and Masatoyo Nishizawa, M.D., Ph.D.1)
CLINICA NEUROL, 54: 1060|1062, 2014
Symposium 12
Pathogenesis of cognitive impairment in multiple sclerosis
Jin Nakahara, M.D.1)
CLINICA NEUROL, 54: 1063|1065, 2014
Symposium 12
Neuronal dysfunction in multiple sclerosis
Tetsuya Mizuno, M.D., Ph.D.1)
CLINICA NEUROL, 54: 1066|1068, 2014
Symposium 14
The infrastructure for the clinical research of muscular dystrophies: Remudy and MDCTN
En Kimura, M.D., Ph.D.1), Harumasa Nakamura, M.D.1), Satomi Mitsuhashi, M.D., Ph.D.1), Fumi Takeuchi, M.D.1), Madoka Mori-Yoshimura, M.D., Ph.D.1), Reiko Shimizu, M.D., Ph.D.1)2), Hirofumi Komaki, M.D., Ph.D.1), Yukiko K Hayashi, M.D., Ph.D.3), Ichizo Nishino, M.D., Ph.D.1), Mitsuru Kawai, M.D.4), and Shin'ichi Takeda, M.D., Ph.D.1)
CLINICA NEUROL, 54: 1069|1070, 2014
Symposium 14
Exon Skipping Approach to Duchenne Muscular Dystorphy
Shin'ichi Takeda, M.D., Ph.D.1)
CLINICA NEUROL, 54: 1071|1073, 2014
Symposium 14
Nonsense readthrough therapy for Duchenne muscular dystrophy
Yasuhiro Takeshima, M.D., Ph.D.1)
CLINICA NEUROL, 54: 1074|1076, 2014
Symposium 14
Therapeutic development in myotonic dystrophy
Masanori P. Takahashi, M.D, Ph.D.1), Masayuki Nakamori, M.D, Ph.D.1) and Hideki Mochizuki, M.D, Ph.D.1)
CLINICA NEUROL, 54: 1077|1079, 2014
Symposium 17
Fasciculation potential and ALS diagnosis
Masahiro Sonoo, M.D., Ph.D.1) and Mana Higashihara, M.D., Ph.D.2)
CLINICA NEUROL, 54: 1080|1082, 2014
Symposium 17
Fasciculation potentials in ALS-significance, and relationship with clinical features
Kota Bokuda, M.D.1) and Toshio Shimizu, M.D., Ph.D.1)
CLINICA NEUROL, 54: 1083|1085, 2014
Symposium 17
Motor nerve hyperexcitability in ALS: its pathophysiology and treatment
Kazumoto Shibuya, M.D., Ph.D.1), Sonoko Misawa, M.D., Ph.D.1) and Satoshi Kuwabara, M.D., Ph.D.1)
CLINICA NEUROL, 54: 1086|1088, 2014
Symposium 18
Neuropsychological thinking at everyday clinical practice
Satoru Motomura, M.D., Ph.D.1)
CLINICA NEUROL, 54: 1089|1091, 2014
Symposium 18
Communication disorder in chronic stage stroke patients
Kazuyo Tanji, M.D.1)
CLINICA NEUROL, 54: 1092|1094, 2014
Symposium 18
Neuropsychology of dementia
Etsuro Mori, M.D., Ph.D.1)
CLINICA NEUROL, 54: 1095|1097, 2014
Symposium 22
Clinical spectrum and treatment strategy in anti-NMDA receptor encephalitis: current status and issues
Takahiro Iizuka, M.D.1), Daisuke Ishima, M.D.1), Juntaro Kaneko, M.D.1) and Kazutoshi Nishiyama, M.D., Ph.D.1)
CLINICA NEUROL, 54: 1098|1102, 2014
Symposium 22
Anti-NMDA Encephalitis in Psychiatry; Malignant Catatonia, Atypical Psychosis and ECT
Takashi Kanbayashi, M.D., Ph.D.1)2), Ko Tsutsui, M.D., Ph.D.1), Keiko Tanaka, M.D., Ph.D.3), Yuki Omori, M.D.1), Manabu Takaki, M.D., Ph.D.4), Mayu Omokawa, M.D.1), Akane Mori, M.D.1), Hiroaki Kusanagi, M.D., Ph.D.1), Seiji Nishino, M.D., Ph.D.5), Tetsuo Shimizu, M.D., Ph.D.1)2)
CLINICA NEUROL, 54: 1103|1106, 2014
Symposium 22
Autoimmune encephalitis-update: Roles of autoantibodies in the pathogenesis
Keiko Tanaka, M.D., Ph.D.1)
CLINICA NEUROL, 54: 1107|1109, 2014
Symposium 30
Recent findings in dermatomyositis-specific autoantibodies
Manabu Fujimoto, M.D.1)
CLINICA NEUROL, 54: 1110|1112, 2014
Symposium 30
Pathological features of myositis with myositis -specific autoantibodies
Jun Shimizu, M.D., Ph.D.1) and Tsuneyo Mimori, M.D., Ph.D.2)
CLINICA NEUROL, 54: 1113|1114, 2014
Symposium 30
Recent progress in diagnosis and pathomechanism of inclusion body myositis
Masashi Aoki, M.D.1), Naoki Suzuki, M.D.1), Masaaki Kato, M.D.1) and Hitoshi Warita, M.D.1)
CLINICA NEUROL, 54: 1115|1118, 2014
Symposium 31
Microglia in neurodegenerative disorders and neuroinflammation
Akio Suzumura, M.D., Ph.D.1)
CLINICA NEUROL, 54: 1119|1121, 2014
Symposium 31
Neurodegenerative disease and TREM2
Kazuya Takahashi, M.D., Ph.D.1)
CLINICA NEUROL, 54: 1122|1124, 2014
Symposium 31
The association of Parkinson's disease pathogenesis with inflammation
Shinji Saiki, M.D. Ph.D.1)
CLINICA NEUROL, 54: 1125|1127, 2014
Symposium 31
Neuroinflammation in amyotrophic lateral sclerosis
Fumito Endo, M.D., Ph.D.1) and Koji Yamanaka, M.D., Ph.D.1)
CLINICA NEUROL, 54: 1128|1131, 2014
Symposium 32
Spontaneous seizures in a rat models of multiple prenatal lesioning
Takashi Kamada, M.D.1), Kei-ichiro Takase, M.D., Ph.D.2) and Hiroshi Shigeto, M.D., Ph.D.3)
CLINICA NEUROL, 54: 1132|1135, 2014
Symposium 32
Histopathologic features of glia in human epileptogenic brain lesions
Akiyoshi Kakita, M.D., Ph.D.1)
CLINICA NEUROL, 54: 1136|1138, 2014
Symposium 32
Epilepsy and functional brain networks
Taira Uehara, M.D.1), Hiroshi Shigeto, M.D., Ph.D.1) and Jun-ichi Kira, M.D., Ph.D.1)
CLINICA NEUROL, 54: 1139|1141, 2014
Symposium 32
Recent advance in research of benign adult familial myoclonus epilepsy (BAFME): Is BAFME a progressive disorder?
Takefumi Hitomi, M.D., Ph.D.1), Ryosuke Takahashi, M.D., Ph.D.2) and Akio Ikeda, M.D., Ph.D.3)
CLINICA NEUROL, 54: 1142|1145, 2014
Symposium 32
Epilepsy in the elderly
Naoki Akamatsu, M.D., Ph.D.1), Akihiro Tanaka, M.D., Ph.D.2), Mitsuhiko Yamano, M.D., Ph.D.3) and Sadatoshi Tsuji, M.D., Ph.D.1)
CLINICA NEUROL, 54: 1146|1147, 2014
Symposium 33
Biochemical abnormality of mutant TDP-43 protein
Koji Yamanaka, M.D., Ph.D.1)
CLINICA NEUROL, 54: 1148|1150, 2014
Symposium 33
Calpain plays a crucial role in TDP-43 pathology
Takenari Yamashita, Ph.D.1) and Shin Kwak, M.D. Ph.D.2)
CLINICA NEUROL, 54: 1151|1154, 2014
Symposium 33
Aberration of the spliceosome in amyotrophic lateral sclerosis
Tomohiko Ishihara, M.D., Ph.D.1)2), Akiyoshi Kakita, M.D., Ph.D.3), Hitoshi Takahashi, M.D., Ph.D.4), Osamu Onodera, M.D., Ph.D.2) and Masatoyo Nishizawa, M.D., Ph.D.1)
CLINICA NEUROL, 54: 1155|1157, 2014
Symposium 01iby non designated speakersj
Clinical and neuroimaging characteristics of patients with hereditary diffuse leukoencephalopathy with spheroids (HDLS)
Takeshi Ikeuchi, M.D., Ph.D.1)
CLINICA NEUROL, 54: 1158|1161, 2014
Symposium 01iby non designated speakersj
MRI comparison between hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS) and primary progressive multiple sclerosis (PPMS)
Ban-yu Saitoh, M.D.1)
CLINICA NEUROL, 54: 1162|1164, 2014
Symposium 01iby non designated speakersj
Neuropathology of hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS)
Kiyomitsu Oyanagi, M.D.1)
CLINICA NEUROL, 54: 1165|1167, 2014
Symposium 01iby non designated speakersj
The new diagnostic methods of CADASIL as differential diagnosis of HDLS
Akihiko Ueda, M.D., Ph.D.1) and Yukio Ando, M.D., Ph.D.1)
CLINICA NEUROL, 54: 1168|1170, 2014
Symposium 05iby non designated speakersj
Diagnosis and treatment of dementia: Overview
Katsutoshi Furukawa, M.D., Ph.D.1), Aiko Ishiki, M.D.1), Naoki Tomita, M.D., Ph.D., M.P.H.1) and Hiroyuki Arai, M.D., Ph.D.1)
CLINICA NEUROL, 54: 1171|1173, 2014
Symposium 05iby non designated speakersj
The contribution of molecular imaging research to innovative drug development
Hitoshi Shimada, M.D., Ph.D.1)
CLINICA NEUROL, 54: 1174|1177, 2014
Symposium 05iby non designated speakersj
Development of disease modifying drugs for dementia-focusing on anti-tau drugs-
Yoshiyuki Soeda, Ph.D.1) and Akihiko Takashima, Ph.D.1)
CLINICA NEUROL, 54: 1178|1180, 2014
Symposium 05iby non designated speakersj
The drug development for overcoming dementia in Japan
Harumasa Nakamura, M.D.1)
CLINICA NEUROL, 54: 1181|1183, 2014
Symposium 06iby non designated speakersj
Classical view of cerebrospinal production, absorption and bulk flow and its criticism
Masatsune Ishikawa, M.D., Ph.D.1)
CLINICA NEUROL, 54: 1184|1186, 2014
Symposium 06iby non designated speakersj
Lymphatic drainage of CSF and ISF from the brain: recent concept and hypothesis
Shinya Kida, M.D., Ph.D.1)
CLINICA NEUROL, 54: 1187|1189, 2014
Symposium 06iby non designated speakersj
A hypothesis of cerebrospinal fluid formation and absorption: from the clinical viewpoint of idiopathic normal pressure hydrocephalus
Etsuro Mori, M.D., Ph.D.1) and Shinya Yamada, M.D., Ph.D.2)
CLINICA NEUROL, 54: 1190|1192, 2014
Symposium 06iby non designated speakersj
The emerging concept of the production and absorption of cerebrospinal fluid, and recent progress in the diagnosis and treatment of iNPH
Takahiko Tokuda, M.D., Ph.D.1)
CLINICA NEUROL, 54: 1193|1196, 2014
Super Expert Session 01
Intravenous thrombolysis for acute ischemic stroke: past, present and future
Mikito Hayakawa, M.D.1)
CLINICA NEUROL, 54: 1197|1199, 2014
Super Expert Session 01
Current and future prospects of endovascular treatment for acute ischemic stroke
Tomonori Iwata, M.D., F.A.H.A.1)
CLINICA NEUROL, 54: 1200|1202, 2014
Super Expert Session 01
Neurologist and emergency neuroendovascular revascularization
-training programs for endovascular procedures-
Keisuke Imai, M.D.1), Masashi Hamanaka, M.D.1), Takehiro Yamada, M.D.1), Hidekazu Yamazaki, M.D.1), Atsushi Yamamoto, M.D.1), Kazuma Tsuto, M.D.1), Tetsuro Takegami, M.D., Ph.D.2), Kunihiko Umezawa, M.D., Ph.D.3), Eito Ikeda, M.D., Ph.D.2) and Toshiki Mizuno, M.D., Ph.D.4)
CLINICA NEUROL, 54: 1203|1206, 2014
Super Expert Session 01
Education for stroke neurologists in neuroendovascular revascularization therapy of acute ischemic stroke
Tatsuro Takada, M.D.1)
CLINICA NEUROL, 54: 1207|1210, 2014
Super Expert Session 01
Change in number of residents who plan to specialize in cerebrovascular disease and neurointervention in the Department of Neurology of Kyushu University Hospital
Shoji Matsumoto, M.D., Ph.D.1)2)
CLINICA NEUROL, 54: 1211|1213, 2014
Super Expert Session 01
Impact of comprehensive stroke team combined with vascular neurologist, neurosurgeon and endovascular interventionist for acute stroke
Yasushi Okada, M.D., Ph.D.1), Yoshiki Sambongi, M.D.1), Yuichiro Tsurusaki, M.D.1), Tomoyuki Tsumoto, M.D., Ph.D.2), Shinji Nagata, M.D., Ph.D.3) and Masahiro Yasaka, M.D., Ph.D.1)
CLINICA NEUROL, 54: 1214|1216, 2014